Adjuvant XXXX therapy in @entity1 with resected @entity157 : evaluation of predictive factors.

@entity1 @entity5 @entity2857 @entity157 @entity204 @entity715 @entity1349
Currently there is no predictor for survival after adjuvant @entity2857 in @entity1 with @entity157 ( @entity157 ) who have undergone curative resection. Thirty-eight @entity1 who underwent curative resection of @entity157 received adjuvant @entity2857 therapy between August 2009 and March 2012. Clinicopathological parameters including @entity1 factors, @entity5 factors, liver background, and inflammatory factors (before surgery and dynamic changes after @entity2857 therapy) were evaluated to identify predictors for @entity1349 ( @entity1349 ) and @entity1349 ( @entity1349 ). The recurrence rate, mortality rate, and clinicopathological data were also compared. Increased NLR after @entity2857 (HR  =  3.199, 95  % CI 1.365-7.545, P  =  0.008), increased GGT after @entity2857 (HR  =  3.204, 95  % CI 1.333-7.700, P  =  0.009), and the presence of @entity715 (HR  =  2.381, 95  % CI 1.064-5.328, P  =  0.035) were risk factors related to @entity1349 . By contrast, increased NLR after @entity2857 was the only independent risk factor related to @entity1349 (HR  =  4.647, 95  % CI 1.266-17.053, P  =  0.021). @entity1 with increased NLR or increased GGT after @entity2857 had a higher incidence of recurrence and @entity204 . @entity1 who had increased NLR tended to have higher preoperative levels of NLR and GGT. There were no differences in clinicopathological factors in @entity1 with increased GGT and decreased GGT. In conclusion, increased NLR predicted a worse @entity1349 and @entity1349 in @entity1 with @entity157 who underwent curative resection with adjuvant @entity2857 therapy. Increased GGT predicted a worse @entity1349 . NLR and GGT can be monitored dynamically before and after @entity2857 therapy.
